Cannabis Strategic Ventures, Inc. (OTC: NUGS) this morning
announced its appointment of Robert H. Cohen M.D. to the position of medical
advisor in support of the further development and research of Halo Filters and
other CBD-related brands. Per the update, Cohen is a cannabis researcher and
highly qualified cosmetic surgeon based in California. His involvement in the
cannabis field dates back to 2007, when he helped perform medical evaluations
for the use of medical marijuana in California, and he has continued to assist
with researching the properties of CBD and the derivatives of medical marijuana
for skincare and overall well-being in the years since. “Dr. Cohen is a great
addition to the NUGS family. His medical expertise will help us continue to
improve our products and communicate the health importance related to
Cannabis,” Simon Yu, CEO of Cannabis Strategic, stated in the news release.
“His cannabis research expertise will advance Halo Filters as well as our
family of brands.”
To view the full press release, visit http://ibn.fm/EvVsm
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is based in Los Angeles and is
focused on supporting entrepreneurial growth within the fast-growing legal
cannabis sector. The Company recently completed a name and symbol change from
Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel
solutions that are tailor made to match the growth dynamics of cannabis
cultivators, manufacturers, dispensaries, and other cannabis marketplace
participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the
Counter Market with the stock symbol NUGS. For more information, visit the
company’s website at www.CannabisStrategic.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
